NASDAQ:CRVS   Corvus Pharmaceuticals, Inc
Consolidation in TF wk is that's all I could say.

Modulating immune system play role in cancer and infection.
In cancer treatment targeted therapy and tailed play major role (High cost of drug of course)

CRVS do the modulating immune system thing

Now let's see what's CRVS do.
What the physicians want is "When can we use this medication/protocol?"
It's phase 3 to use in human before FDA approves

Phase 3 is important when you do research

Here what's they do

Phase 1 CPI-006 (B cell activation -> immune system thing about white blood cell)

Phase 1B-2 Ciforadenant Renal cell, prostate
Phase 1 CPI 818 T-cell lymphoma (white blood cell cancer)

So the factors that the price will surge are:-
-Positive Research outcome
-Phase 3
-FDA approve

that's all

Comment: higher low
Comment: I sold this junk at January 2021 and never look back again. I bought $SPWR and $SE. I'm glad I've made my right decision.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.